Trastuzumab pharmacokinetics influenced by extent human epidermal growth factor receptor 2-positive tumor load.
Oude Munnink
Thijs H
TH
Dijkers
Eli C
EC
Netters
Sabine J
SJ
Lub-de Hooge
Marjolijn N
MN
Brouwers
Adrienne H
AH
Haasjes
Janny G
JG
Schröder
Carolina P
CP
de Vries
Elisabeth G
EG
D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D005260:Female; D006801:Humans; D011868:Radioisotopes; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D000068878:Trastuzumab; D015040:Zirconium
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D011868:Radioisotopes; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; D015040:Zirconium; C508053:ERBB2 protein, human